85 related articles for article (PubMed ID: 17332623)
1. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
Hsu AR; Cai W; Veeravagu A; Mohamedali KA; Chen K; Kim S; Vogel H; Hou LC; Tse V; Rosenblum MG; Chen X
J Nucl Med; 2007 Mar; 48(3):445-54. PubMed ID: 17332623
[TBL] [Abstract][Full Text] [Related]
2. Theranostic role of
Yang Q; Chen Z; Qiu Y; Huang W; Wang T; Song L; Sun X; Li C; Xu X; Kang L
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1246-1260. PubMed ID: 38135849
[TBL] [Abstract][Full Text] [Related]
3. Light-enhanced VEGF
Longva AS; Berg K; Weyergang A
Front Immunol; 2023; 14():1278000. PubMed ID: 38173721
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Light-enhanced VEGF
Longva AS; Berg K; Weyergang A
Front Immunol; 2023; 14():1359973. PubMed ID: 38264651
[TBL] [Abstract][Full Text] [Related]
5. Integrin alphavbeta3-targeted radioimmunotherapy of glioblastoma multiforme.
Veeravagu A; Liu Z; Niu G; Chen K; Jia B; Cai W; Jin C; Hsu AR; Connolly AJ; Tse V; Wang F; Chen X
Clin Cancer Res; 2008 Nov; 14(22):7330-9. PubMed ID: 19010848
[TBL] [Abstract][Full Text] [Related]
6. Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.
Laudicella R; Quartuccio N; Argiroffi G; Alongi P; Baratto L; Califaretti E; Frantellizzi V; De Vincentis G; Del Sole A; Evangelista L; Baldari S; Bisdas S; Ceci F; Iagaru A;
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3925-3939. PubMed ID: 33851243
[TBL] [Abstract][Full Text] [Related]
7. The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy.
Masłowska K; Halik PK; Tymecka D; Misicka A; Gniazdowska E
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802353
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging of VEGFR with a Novel
Hu K; Shang J; Xie L; Hanyu M; Zhang Y; Yang Z; Xu H; Wang L; Zhang MR
ACS Omega; 2020 Apr; 5(15):8508-8514. PubMed ID: 32337411
[TBL] [Abstract][Full Text] [Related]
9. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.
Werner JM; Lohmann P; Fink GR; Langen KJ; Galldiks N
Molecules; 2020 Mar; 25(6):. PubMed ID: 32213992
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential.
Wang L; Habib AA; Mintz A; Li KC; Zhao D
Mol Imaging; 2017 Jan; 16():1536012117708722. PubMed ID: 28654387
[TBL] [Abstract][Full Text] [Related]
11. Fms related tyrosine kinase 1 (Flt1) functions as an oncogene and regulates glioblastoma cell metastasis by regulating sonic hedgehog signaling.
Jiang K; Wang YP; Wang XD; Hui XB; Ding LS; Liu J; Liu D
Am J Cancer Res; 2017; 7(5):1164-1176. PubMed ID: 28560064
[TBL] [Abstract][Full Text] [Related]
12. Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.
Hatt M; Lee JA; Schmidtlein CR; Naqa IE; Caldwell C; De Bernardi E; Lu W; Das S; Geets X; Gregoire V; Jeraj R; MacManus MP; Mawlawi OR; Nestle U; Pugachev AB; Schöder H; Shepherd T; Spezi E; Visvikis D; Zaidi H; Kirov AS
Med Phys; 2017 Jun; 44(6):e1-e42. PubMed ID: 28120467
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET.
Guo N; Zhang F; Zhang X; Guo J; Lang L; Kiesewetter DO; Niu G; Li Q; Chen X
Mol Imaging Biol; 2015 Dec; 17(6):865-73. PubMed ID: 25896816
[TBL] [Abstract][Full Text] [Related]
14. VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.
Goel S; Chen F; Hong H; Valdovinos HF; Hernandez R; Shi S; Barnhart TE; Cai W
ACS Appl Mater Interfaces; 2014 Dec; 6(23):21677-85. PubMed ID: 25353068
[TBL] [Abstract][Full Text] [Related]
15. Modulation, bioinformatic screening, and assessment of small molecular peptides targeting the vascular endothelial growth factor receptor.
Feng S; Zou L; Ni Q; Zhang X; Li Q; Zheng L; Xie L; Li H; Huang D
Cell Biochem Biophys; 2014 Dec; 70(3):1913-21. PubMed ID: 25069724
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models.
Xu QH; Shi JY; Zhang J; Sun YF; Chang AH; Zhao YM; Cai WJ; Liu D; Zhou CC; Fan LH; Su B
Clin Transl Oncol; 2014 Apr; 16(4):395-401. PubMed ID: 23979910
[TBL] [Abstract][Full Text] [Related]
17. The influence of interpreters' professional background and experience on the interpretation of multimodality imaging of pulmonary lesions using 18F-3'-deoxy-fluorothymidine and 18F-fluorodeoxyglucose PET/CT.
Xu BX; Liu CB; Wang RM; Shao MZ; Fu LP; Li YG; Tian JH
PLoS One; 2013; 8(4):e60104. PubMed ID: 23565188
[TBL] [Abstract][Full Text] [Related]
18. Molecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma.
Thompson SM; Callstrom MR; Knudsen BE; Anderson JL; Sutor SL; Butters KA; Kuo C; Grande JP; Roberts LR; Woodrum DA
Invest Radiol; 2013 Jun; 48(6):413-21. PubMed ID: 23262791
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.
Zhang Y; Hong H; Niu G; Valdovinos HF; Orbay H; Nayak TR; Chen X; Barnhart TE; Cai W
Mol Pharm; 2012 Dec; 9(12):3586-94. PubMed ID: 23137334
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel.
Mohamedali KA; Niu G; Luster TA; Thorpe PE; Gao H; Chen X; Rosenblum MG
Biochem Pharmacol; 2012 Dec; 84(11):1534-40. PubMed ID: 23022224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
